Pitcairn’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
64,249
+2,266
| +4% | +$38K | 0.07% | 243 |
|
|
2025
Q1 | $953K | Buy |
61,983
+1,096
| +2% | +$16.8K | 0.06% | 284 |
|
|
2024
Q4 | $1.34M | Buy |
60,887
+8,312
| +16% | +$183K | 0.08% | 216 |
|
|
2024
Q3 | $947K | Buy |
+52,575
| New | +$947K | 0.06% | 283 |
|
|
2016
Q4 | – | Sell |
-13,790
| Closed | -$635K | – | 521 |
|
|
2016
Q3 | $635K | Buy |
+13,790
| New | +$635K | 0.08% | 200 |
|
|
2016
Q2 | – | Sell |
-12,313
| Closed | -$659K | – | 478 |
|
|
2016
Q1 | $659K | Sell |
12,313
-458
| -4% | -$24.5K | 0.08% | 194 |
|
|
2015
Q4 | $839K | Buy |
+12,771
| New | +$839K | 0.09% | 160 |
|